South Korea AI ETF Dips 19% in July Amid Global Capital Rotation
By Market Desk
South Korea’s AI ETF saw a 19% drop in July due to global capital rotation towards Singapore and Brazil, despite strong year-to-date gains.
South Korea’s iShares MSCI South Korea ETF experienced a notable 19% decline in July 2026, driven by a significant rotation of global capital. Despite this monthly correction in artificial intelligence and semiconductor stocks, the ETF still maintains robust year-to-date gains of 77% and a substantial 140% over the past twelve months.
Global Capital Shifts Direction
Investors actively reallocated capital away from the concentrated AI-chip trade during July. This strategic shift saw Singapore and Brazil emerge as primary beneficiaries of the redirected funds.
The iShares MSCI Singapore ETF recorded an impressive 11% gain for July, elevating its year-to-date return to 19%. Concurrently, the iShares MSCI Brazil Capped ETF saw a 4% monthly increase, bringing its year-to-date gains to 14% and its annual performance to 36%.
India Markets See Headwinds
In contrast to the gains observed in other emerging markets, India-focused investment vehicles faced challenges. The MSCI India ETF declined by 1.5% in July, primarily due to prevailing domestic market weakness and a depreciating rupee.
Its year-to-date performance showed a 10% decline, with a further 12% drop over the past year. Even the small-cap segment within India managed only modest gains during this period, indicating broad market softness.
Emerging Investment Themes
Beyond the now-crowded AI sector, market participants are actively exploring new investment avenues. Biotechnology and genomics sectors demonstrated strong performance in July.
Biotechnology posted significant gains of 16.2%, while genomics recorded an even higher increase of 21.1% during the month. Cybersecurity and insurance also exhibited positive momentum, drawing investor interest.
Notably, Chinese semiconductor companies, as measured by the Harvest SSE STAR Chip Index ETF, outperformed their South Korean counterparts. Analysts anticipate that future investment themes will encompass pharmaceutical advancements, various healthcare-related technologies, and specific segments of the Chinese market, with the sustainability of these rotations being a critical factor for investors.